Public tenders and centralized drug purchasing
Public tenders and centralized drug purchasing
New Institute for Health Metrics and Evaluation estimates show global health financing dropped 5% in 2026, following a 12% cut in 2025, as the UK posted the largest absolute reduction …
At its second meeting, Panama’s National System of Reference Prices for Medicines (SINPREM) approved its operating statute. The Ministry of Health and the Social Security Fund agreed to bring their …
Mexico’s Ministry of Health and state-owned BIRMEX awarded 673 codes worth MXN 34.4 billion in the third public tender of the 2027–2028 consolidated purchase, bringing coverage to about 90% of …
Panama has installed the National System of Reference Prices for Medicines (SINPREM), a system created by Law 419 of 2024 that pools the drug needs of the Ministry of Health …
A MXN 3,510.2 million inter-institutional compensation line in Mexico’s 2027 budget proposal is meant to finance the Servicio Universal de Salud (SUS) as it starts in 2027, even as IMSS …
Resolution 1447/2026 replaces the 2021 primary-care essential medicines list behind Argentina’s Remediar programme with a list focused on vascular disease, leaving other conditions to provincial procurement after a transition kit …
A Mexican health-systems researcher warns that the new scheme could generate more demand than the social-security institutions can absorb, and that far more public investment is indispensable, though not sufficient, …
Mexico’s pharmaceutical and medical-device industry chamber, Canifarma, says 650–700 medicine listings have been removed from Mercado Libre under a June 2026 brand-protection agreement, and warns that public health-sector medicines are …
Brazil’s federal health ministry began dispensing nine new cancer drugs through the public Sistema Único de Saúde (SUS) network this week, for more than 116,000 patients, and expects all 23 …
Chileans spend nearly US$100 million a year on weight-loss treatment, according to La Tercera, as seven generic semaglutide applications — including Laboratorio Chile’s Selfix — await regulatory review, putting Novo …
You must be logged in to post a comment.